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EVALUATION OF RECENTLY DEVELOPED METHODS  
 
FOR THE FORENSIC DETECTION OF MENSTRUAL BLOOD  
 
 
KETKI BAGWE 
 
ABSTRACT 
 
Body fluid identification is an important aspect of forensic work, as it can help 
identify a suspect and provide information about the kind of criminal activity that took 
place. Blood is one of the most commonly found body fluids at a crime scene. While 
visually it is easily distinguishable from other fluids, an accurate method is needed to 
differentiate between peripheral blood and menstrual blood.  This differentiation could 
provide critical evidence regarding consent in an alleged sexual assault. The presence of 
peripheral blood indicates a traumatic cause, whereas menstrual blood points towards a 
natural bleeding cause. Accurate detection of menstrual blood can also help with the 
reconstruction or corroboration of events.  
Menstruation is the shedding of the internal lining of the uterus that occurs on a 
monthly basis in women of a reproductive age group. Menstrual blood is different in 
composition from the peripheral blood flowing through arteries and veins. It consists of a 
mixture of vaginal and cervical secretions, epithelial cells, debris from the endometrial 
lining, blood and fibrinolytic products. The fibrinolytic products are associated with the 
prevention of blood clot formation. Several methods have been researched and used for the 
detection of menstrual blood. These include microscopy, identification of the lactate 
dehydrogenase isoenzyme, detection of fibrinolytic products, and profiling of messenger 
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ribonucleic acid (mRNA) and micro RNA (miRNA). Even though menstrual blood is 
encountered at crime scenes, a reliable routine procedure for its identification has not yet 
been incorporated in forensic laboratories.  
In this study, four methods of detection of menstrual blood were evaluated and 
compared with each other regarding efficacy. These methods are the LGC ParaDNAÒ 
Body Fluid ID Test, SERATECÒ PMB Test, DIMERTESTÒ Latex Assay and Microscopic 
methods using Lugol’s Iodine and Dane’s staining method. The LGC ParaDNAÒ Body 
Fluid ID Test identifies menstrual blood by detecting the mRNA marker MMP10.  The 
SERATECÒ PMB Test and DIMERTESTÒ Latex Assay both detect D-dimers present in 
menstrual blood. In addition, the SERATECÒ PMB Test can detect the presence of 
peripheral blood.  Microscopic identification is performed by identifying vaginal epithelial 
cells present in the menstrual blood. Menstrual blood samples were self-collected from six 
anonymous donors on three consecutive days of menses on either a cotton swatch or a 
cotton swab.  Samples from the earliest day were tested in triplicate using the first three 
methods. For the fourth method, Lugol’s Iodine and Dane’s stain were applied to various 
cell types to test the utility of the stains.  
The ParaDNAÒ Body Fluid ID Test, SERATECÒ PMB test and the DIMERTESTÒ 
Latex Assay all show promise for the detection of menstrual blood in forensic samples. 
None of the tests showed a cross reactivity to the other body fluids tested, but some 
ParaDNAÒ and DIMERTESTÒ samples yielded a false negative result for menstrual blood 
or peripheral blood. The SERATECÒ PMB Test outperformed the other methods, both in 
sensitivity and accuracy. It was accurate for all samples, with a short run time and minimal 
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training required. Microscopic detection of menstrual blood via detection of vaginal 
epithelial cells could not be accurately investigated as Dane’s staining method could not 
be reproduced and the presence of blood obscured the results for the Lugol’s method. 
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1. INTRODUCTION 
1.1 Menstrual Blood in Forensics 
Body fluid identification is an important aspect of forensic work, as it can help 
identify a suspect and provide information about the kind of criminal activity that took 
place.1 Identifying the biological source of a stain can be done both at a crime scene and at 
the laboratory. Body fluids of interest at a crime scene include blood, menstrual blood, 
semen, vaginal fluid and saliva. Blood is one of the most commonly found body fluids at 
a crime scene. While visually it is easily distinguishable from the other fluids, an accurate 
method is needed to differentiate between peripheral blood and menstrual blood. This is 
because it can provide critical evidence regarding consent in an alleged sexual assault, 
particularly where the presence of blood is alleged to be a result of consensual sex with a 
partner in menses .2 The presence of peripheral blood may indicate a traumatic cause or 
support the possibility that a violent act had occurred.3 Accurate detection of menstrual 
blood can also help with the reconstruction or corroboration of events. 
 
1.2 Menstruation and Composition of Menstrual Blood 
 Menstruation is the shedding of the internal lining of the uterus that occurs on a 
monthly basis in women of a reproductive age group. The average menstrual cycle is 
around 28 days, measured from the first day of one cycle to the first day of the next. A 
deviation of two or three days is common. The rhythm of the cycle is dependent on 
hormones. The wall of the uterus consists of three layers: outer perimetrium, middle 
myometrium and internal endometrium. During menstruation, the superficial layer of the 
2 
endometrium is shed due to hormonal changes. Bleeding occurs as the blood vessels 
present in this layer are damaged during the process of shedding. Figure 1 depicts the cross-
section of the endometrium over the course of the entire cycle. The differences in thickness 
are illustrated, with the endometrium being the thinnest after menstruation as most of it is 
shed. The coiled arteries inside the wall are also depicted and represent the vessels that are 
damaged and result in bleeding. The duration of bleeding is three to five days and the 
average blood loss is approximately between 50 to 200 mL.4 
 
Figure 1: Endometrial Histology During the Menstrual Cycle5. Cross-section of the 
endometrium over the course of the menstrual cycle, showing the varying thickness, and 
blood vessels in the wall. 
 
Menstrual blood is different in composition from the peripheral blood flowing 
through arteries and veins. It consists of a mixture of vaginal and cervical secretions, 
epithelial cells, debris from the endometrial lining, blood and fibrinolytic products.4 The 
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fibrinolytic products are associated with the prevention of blood clot formation. Normally, 
if a tissue or vessel is wounded, the clotting mechanism is activated in order to prevent 
major blood loss. As the vessels in the endometrium are damaged, the clotting process gets 
activated. In order for the blood to efficiently flow out of the vagina and not accumulate in 
the uterus, it is important for it to remain in liquid form. Hence, the presence of fibrinolytic, 
or clot dissolving substances, in menstrual blood.  
 
1.3 Methods of Detection of Menstrual Blood to Date 
 Several methods have been researched and used for the detection of menstrual 
blood. These include microscopy, identification of the lactate dehydrogenase isoenzyme, 
detection of fibrinolytic products, and profiling of messenger ribonucleic acid (mRNA) and 
micro RNA (miRNA).6 
 
1.3.1 Microscopic and histological methods 
 One of the oldest methods used to detect menstrual blood is based on the 
microscopic observation of vaginal epithelial cells. Skin, buccal and vaginal cells are 
classified as stratified squamous epithelial cells. Skin cells differ morphologically in that 
they generally lack nuclei and are keratinized. Vaginal and buccal epithelial cells are 
indistinguishable morphologically, with both containing nuclei. However, they can be 
distinguished by the fact that a certain percentage of vaginal cells in women of a 
reproductive age contain glycogen granules. Lugol’s iodine has been in use for many years 
to detect glycogen and identify vaginal epithelial cells microscopically.6 This method does 
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not have absolute specificity to vaginal cells, since some buccal epithelial cells and cells 
of the male urinary tract also contain a small amount of glycogen granules.7, 8 These are 
present in a very low concentration as compared to vaginal cells, but can lead to false 
positives. Also, menstrual bloodstains do not always give positive results with glycogen 
detection techniques as they may lack epithelial cells. Furthermore, other types of blood 
stains, such as blood shed during an abortion, labor or puerperium, also contains glycogen.9 
Although this method of detecting vaginal cells is well known, it is still not routinely used 
by forensic laboratories for the purpose of identifying menstrual blood.  
 
1.3.2 Lactate Dehydrogenase (LDH) Isoenzyme Identification 
 Lactate dehydrogenase (LDH) was the first enzyme recognized as having multiple 
molecular forms or isoenzymes.6 Isoenzymes have the ability to catalyze the same 
biochemical reactions in spite of having different molecular structures. LDH can be 
separated into five bands using electrophoresis (Figure 2). The five different isoenzymes 
are characteristic to a particular organ or tissue. Menstrual bloodstains show a higher 
proportion of the isoenzymes LDH-4 and LDH-5.10 This high level is related to the 
presence of endometrial components and a high concentration of leucocytes. However, 
there is also an increase seen with cadaveric blood as well as blood shed during delivery. 
Stombaugh and Kearney11 showed a considerable overlap in the LDH-4 and LDH-5 ranges 
obtained from menstrual, cadaveric, umbilical cord and peripheral blood. LDH levels vary 
from donor to donor as well as within different days of the menstrual cycle. Research has 
also shown that vaginal swabs free of blood and semen may show the presence of LDH-4 
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or LDH-5, giving a positive result to a mixture of peripheral blood and vaginal secretions.12 
Hence, this method is not satisfactory in discriminating menstrual blood from other types 
of body fluids.  
 
Figure 2: LDH isozyme patterns. Visual depiction of electrophoretic bands.13 
 
 
1.3.3 Detection of Fibrinolytic Products 
 One of the most notable differences between menstrual blood and peripheral blood 
is that menstrual blood does not clot.14 In peripheral blood, the clotting process consists of 
three main steps: 
1. Prothrombin activator complex is formed when a vessel is damaged. 
2. This complex catalyses the activation of prothrombin to thrombin, which is a 
proteolytic enzyme. 
3. Thrombin cleaves fibrinogen into peptides, which polymerize onto fibrin 
threads, forming the clot. 
Several other coagulation factors are involved. The clot lysis process on the other hand 
requires the activation of plasminogen to plasmin, which is a proteolytic enzyme that 
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digests the fibrin threads of a clot. This produces various fibrin-fibrinogen degradation 
products (FDPs) including D-dimer (Figure 3). Menstrual blood is devoid of the numerous 
clotting factors present in peripheral blood. Prothrombin, free thrombin, fibrinogen, and 
fibrin are absent from menstrual blood. Instead, menstrual blood is rich in tissue 
plasminogen activator and FDPs. This fact has been used to differentiate menstrual blood 
from peripheral blood, which contains less FDPs.  
 
 
 
 
 
 
  
 
  
 
Figure 3: Formation of D-dimer by Fibrinolysis. Thrombin acts on fibrinogen forming the clot, 
that is, the cross-linked fibrin. Plasmin dissolves this clot to form D-dimers.  
 
D-Dimer, a specific fragment of FDP, has recently been evaluated for its 
effectiveness in identification of menstrual blood. D-Dimer has been used in various assays 
in the clinical setting for the diagnosis of thrombosis. Miyaishi et al.15 demonstrated that 
menstrual blood has a mean concentration of D-dimer 200 times greater than peripheral 
Thrombin 
Fibrinogen 
Soluble Fibrin 
+ FP A+B 
Fibrin (cross linked) 
XIIIa 
D-dimers 
Plasminogen activators 
Plasminogen Plasmin 
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blood. Having said that, FDPs and D-dimers do increase in concentration in peripheral 
blood under various blood conditions, such as thrombosis, as well as in post-mortem blood. 
Generally, a cut-off level of 500 ng/mL Fibrinogen equivalent units (FEU) or 250 ng/mL 
D-dimer unit is used for clinical diagnosis. If the concentration in peripheral blood is below 
this, blood disorders can be excluded. FDP and D-dimer assays still hold value in being 
quick, simple tests for the identification of menstrual blood, with minimal training required. 
However, all research regarding the use of these products has been performed using clinical 
immunochromatographic assays. Baker examined four D-dimer assays for sensitivity and 
specificity regarding menstrual blood and reported Clearview SimplifyÒ D-Dimer (Alere, 
Chesire, UK) to be the best among them.2 Originally developed to detect D-dimers in 
peripheral blood as an indicator of thromboembolism, a study validating the kit for forensic 
use was published in 2014.16 Recently, a duplex lateral flow immunochromatographic 
assay called SERATECÒ PMB test (SERATECÒ, Göttingen, Germany) has been 
developed which combines the detection of human hemoglobin and D-dimers. This is the 
first such test developed specifically for forensic use.17 
 
1.3.4 Profiling of mRNA and microRNA 
 One method of menstrual blood identification is to detect mRNA markers 
exclusively expressed in endometrial tissue and not in peripheral blood or epithelial cells. 
In a cell, mRNA is responsible for the transfer of genetic information from 
deoxyribonucleic acid (DNA) to proteins. Therefore, the mRNA pattern found in cells is 
cell-specific and determined by the cell type and function. RNA can be amplified using 
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reverse transcription-polymerase chain reaction (RT-PCR). RNA is first transcribed back 
into DNA (called complementary DNA or cDNA) using the enzyme reverse transcriptase. 
Messenger RNA markers are chosen which are specific to a particular tissue type and are 
amplified using RT-PCR to aid in detection of the type of body fluid/tissue.18  
 Matrix metalloproteinases (MMP) are zinc dependent endopeptidases expressed 
when tissue degradation and remodeling is required during menstruation.19 MMP 
expression is cycle-dependent with high mRNA levels during menstruation and the late 
secretory phase of the menstrual cycle.14, 20 MMPs 7, 10 and 11 have been shown to be 
reliable markers for menstrual blood.18 However, false positive results have been observed 
in cases of tumors,21 during fetal development22 and during wound healing.23 Similarly, it 
has been observed that false negative results can occur with MMP11 if the sample is from 
the first day of menstruation, since endometrial cells can be completely absent or only 
partially present. RNA is also more fragile than DNA and is subject to degradation during 
storage due to environmental factors or during analysis. 
  MicroRNAs are pieces of RNA that are smaller in length (approximately 23 
nucleotides) and less vulnerable to degradation than mRNAs. Similar to mRNA, tissue 
specific miRNA expression profiles have been observed.24 Some miRNA markers for the 
identification of menstrual blood have been studied but not confirmed.25 
The use of mRNA and miRNA amplification for body fluid identification requires 
a high level of expertise, specialized equipment and is a high cost manual process. Thus, it 
would be advantageous to develop an automated process for forensic use.  
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1.4 Methods Evaluated in this Study 
1.4.1 LGC ParaDNAÒ Body Fluid ID Test  
The ParaDNAÒ instrument (LGC Limited, London, UK) is a compact thermal 
cycler in conjunction with a basic desktop computer or laptop, which runs the software 
(Figure 4). Samples are collected using the ParaDNAÒ Sample Collector and inserted into 
reaction plates. These plates are then loaded into the instrument head for analysis. LGC has 
developed three tests involving the ParaDNAÒ software. The ParaDNAÒ Screening Test 
analyzes samples collected to see the suitability for downstream DNA processing and 
analysis by conducting a triage analysis.  First, it is determined if human DNA is present 
in the sample, a relative quantitative assessment of the amount of DNA present is given 
and the gender of the contributor is identified. The ParaDNAÒ Intelligence Test is also a 
triage tool, but provides additional information in the form of a 5 loci short tandem repeat 
(STR) DNA profile. The resulting profile can be used to search databases or compare with 
reference samples. The newly developed addition is the ParaDNAÒ Body Fluid ID Test 
which can be used to screen for multiple body fluids simultaneously and confirm the 
presence of specific fluids. Body fluids are identified using mRNA markers specific to a 
particular body fluid. Most mRNA profiling methods are multi-stage processes that require 
experts with experience in RNA analysis and interpretation. ParaDNAÒ Body Fluid ID 
Test is a rapid, one-step, easy to use method which gives automated results in 
approximately 90 minutes. It can identify up to six different body fluids namely saliva, 
peripheral blood, menstrual blood, vaginal fluid, seminal fluid, and spermatozoa.26  
10 
    
Figure 4: LGC ParaDNAÒ Body Fluid ID Test Instrument. Left: Instrument in conjunction with 
computer; Right: Instrument head opened with slot for reaction plate exposed. 
 
 
1.4.1.1 mRNA markers used 
 As previously stated, mRNA is useful in body fluid identification as it is unique to 
specific proteins and thus, to specific body fluids. The mRNA marker used in the 
ParaDNAÒ Body Fluid ID Test for the detection of menstrual blood is MMP10 (Table 1). 
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Table 1: RNA markers analyzed in the ParaDNAÒ Body Fluid ID Test26 
mRNA Marker Body Fluid Detected 
SEMG1 Semen 
PRM2 Sperm 
CYP2B7P1 Vaginal Fluid 
MMP10 Menstrual Blood 
ALAS2 Peripheral Blood 
HTN3 Saliva 
 
The mRNA is transcribed to cDNA via RT-PCR followed by an asymmetric PCR to 
amplify the cDNA strand of interest. 
 
1.4.1.2 Asymmetric PCR 
 Asymmetric PCR is a type of PCR in which there is preferential amplification of a 
single strand of DNA. This is accomplished by varying the ratios of the forward and reverse 
primers in such a way that the primers for the target strand are in excess. As amplification 
proceeds, the primer with lower concentration is incorporated into the double-stranded 
DNA and is eventually exhausted. The remaining amount of the other primer continues the 
synthesis, but only of the chosen strand. 
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1.4.1.3 HyBeaconsÒ fluorescent probe technology 
 ParaDNAÒ uses LGC’s proprietary HyBeaconsÒ fluorescent probe technology to 
process data. HyBeaconsÒ are short lengths of synthesized DNA that are labeled with 
fluorescent dyes. These molecules fluoresce brightly when attached to complementary 
DNA. Fluorescent dye-labeled probes target specific informative RNA marker sequences 
found on the complementary DNA strand that have been chosen for their amenability to 
the HyBeaconsÒ technology.27 
These sequences on the cDNA are amplified using PCR and after cooling down, a 
blocker molecule binds to the target DNA sequence.  Blocker molecules are 
oligonucleotides that competitively bind to the target sequence.  Next, the HyBeaconsÒ 
probe binds to the remaining sequence, and causes the dye to fluoresce. As the temperature 
increases, the probe will melt off the target sequence causing a measureable decrease in 
fluorescence (Figure 5).28  
13 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Representation of the HyBeaconsÒ process. The blocker molecule binds to the target 
DNA sequence and the HyBeaconsÒ probe then binds to the remaining available repeats causing 
fluorescence. The reaction is then heated and the probe melts off, reducing fluorescence.28 
 
 
 
1.4.2 SERATECÒ PMB Test 
 SERATECÒ HemDirect (SERATECÒ, Göttingen, Germany) is an 
immunochromatographic test that detects the presence of human hemoglobin and 
therefore, detects the presence of blood. This was used as the basis for the development of 
a test to detect D-dimer, thus detecting menstrual blood.29 The SERATECÒ PMB Test is a 
novel duplex chromatographic immunoassay for the simultaneous detection of human 
blood and/or menstrual blood in forensic case samples. It detects the presence of human 
hemoglobin and D-dimer. According to the user instructions, the test is easy to use and 
Hot 
Hot 
Cold 
Target DNA Sequence 
Blocker Attached 
Probe attached + fluorescence 
Probe melts off and 
fluorescence decreases 
14 
gives rapid results within 10 minutes. The test has a high sensitivity and detects human 
hemoglobin down to 20 ng/mL and D-dimer down to 400 ng/mL. Moreover, the remaining 
portion of the sample extract remains suitable for DNA extraction and profiling.  
The PMB test cassette contains a sample well and a result window. The result 
window has a control line labeled “C”, a result line for hemoglobin labeled “P” for 
peripheral blood, and a result line for D-dimer labeled “M” for menstrual blood. The assay 
contains four monoclonal and two polyclonal antibodies. Two gold-labeled monoclonal 
antibodies, for the respective epitopes of human hemoglobin and D-dimer, are located in 
the sample area and two monoclonal antibodies are fixed at the test line. The two polyclonal 
antibodies are fixed at the control line. This test utilizes the antibody-antigen-antibody 
sandwich method. The antigen in the sample binds to the dye labeled antibody to form an 
antigen-antibody complex in the sample well. This complex migrates to the test zones and 
forms a complex with the antibodies immobilized there. Accumulation of this dye labeled 
complex results in the formation of a pink line. The unbound labeled antibody binds to the 
polyclonal antibodies at the control zone to form another pink line. Three colored lines 
(one each at C, P and M) indicate the presence of human hemoglobin and D-dimer, strongly 
indicating the presence of menstrual blood or a mixture of human peripheral blood and 
menstrual blood. Two colored lines, at C and P, and no line at M indicates the presence of 
human hemoglobin, and is a strong indication of human peripheral blood. Two colored 
lines, at C and M, and no line at P means that D-dimer is being detected; however, it is 
unlikely that in such a case the concentration of hemoglobin would be below detection 
15 
threshold, as menstrual blood will always contain hemoglobin. In this case, a possibility 
that the hemoglobin signal dropped out due to high dose hook effect should be considered.  
 
1.4.3 DIMERTESTÒ Latex Assay 
 DIMERTESTÒ Latex Assay (Sekisui Diagnostics LLC, Lexington, MA, USA) is a 
rapid qualitative or a semi-quantitative test for derivatives of cross-linked fibrin 
degradation products (XL-FDP) in human plasma. It is a clinical test devised to detect 
elevated levels of XL-FDPs in human plasma in patients suffering from disseminated 
intravascular coagulation (DIC) and vascular diseases such as pulmonary embolism and 
deep vein thrombosis. Normal peripheral blood/plasma does not have XL-FDP levels that 
can be detected by this test. Also, fibrinolytic activity is present in menstrual blood, so this 
assay can be utilized as a way to detect menstrual blood and distinguish it from peripheral 
blood. As blood clots, fibrinogen is converted to fibrin by thrombin and fibrin monomers 
polymerize to form a soluble gel of non-cross-linked fibrin. This is then converted to cross-
linked fibrin by thrombin activated Factor XIII to form an insoluble fibrin clot. Fibrinogen 
and fibrin are both cleaved by plasmin to form degradation products, but only degradation 
products from cross-linked fibrin contain D-dimer.30, 31, 32 These, therefore, are a specific 
marker for fibrinolysis.  
DIMERTESTÒ Latex is a rapid agglutination assay which uses latex beads coated 
with a highly specific D-dimer monoclonal antibody Mab DD-3B6/22.33 XL-FDP present 
in the sample binds to the coated latex beads resulting in an agglutination reaction visible 
to the naked eye when the D-dimer concentration is above the detection threshold. 
16 
According to the manufacturer’s user instructions, this test detects D-dimer levels down to 
200 ng/mL, with no reported false positives.34 
 
1.4.4 Microscopic Examination 
 Microscopic identification of vaginal epithelial cells is a method that has been 
studied for years. Among the various stains historically used to preferentially stain 
epithelial cells, Lugol’s iodine is one of the oldest.6  A novel method recently developed is 
a histologically based technique using the Dane’s staining method.35 
 
1.4.4.1 Lugol’s Iodine Staining Method 
 Lugol’s test is an iodine-based test to detect glycogen in nucleated squamous 
epithelial cells. The test works on the principle that vaginal epithelial cells have a very high 
glycogen content during the reproductive period (menarche to menopause). On average, 
25% of vaginal cells show the presence of glycogen.36 Lugol’s iodine contains iodine, 
which stains the glycogen, and potassium iodide, which allows the iodine to be soluble in 
water. Iodine atoms fit into the helices of glycogen to form a chocolate brown glycogen-
iodine complex. Cellular cytoplasm is chocolate brown in appearance with a clear, round 
unstained nucleus; non-glycogenated cells stain golden yellow. The detection of 
approximately 10% of glycogenated cells is considered a presumptive indication of the 
presence of vaginal epithelium because lower concentrations may be detected in the mouth, 
penile urethra and rectum.37, 38 
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1.4.4.2 Dane’s Staining Method 
 Although skin, buccal and vaginal epithelial cells all belong to the class of stratified 
squamous epithelium, skin cells can be distinguished by the fact that they are keratinized 
and have no nuclei. Buccal and vaginal epithelial cells are indistinguishable 
morphologically. Although Lugol’s and periodic acid-Schiff can stain vaginal cells, they 
cannot distinguish between vaginal and other cells containing glycogen such as oral and 
urinary tract cells. Dane’s staining method has been developed to distinguish between all 
three types of cells- skin, buccal and vaginal. Using this stain, skin cells are stained red and 
orange with no nuclei, buccal cells are stained predominantly orange-pink with red nuclei, 
and vaginal cells are stained bright orange with orange nuclei and a distinct blue hue 
surrounding the cell.39 
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2. MATERIALS AND METHODS 
2.1 Sample Collection 
Menstrual blood samples were self-collected from six anonymous donors on three 
consecutive days of menses on either a cotton swatch or a cotton swab. Peripheral blood 
samples were also collected from the same donors by finger prick onto filter paper. All 
samples were stored at room temperature throughout the study. Sample donations were 
obtained in accordance with a protocol approved for research by the Boston University 
School of Medicine Institutional Review Board. Samples from the earliest day of menses 
provided (Day 1 or 2) were chosen to be tested for each donor. 
 
2.2 Method I - LGC ParaDNAÒ Body Fluid ID Test 
The reaction plate, which was stored at -20°C, was allowed to thaw for fifteen 
minutes and then spun down in a centrifuge at 3000 rpm for approximately ten seconds. 
The ParaDNAÒ Sample Collector is a plastic device with a handle at one end and four 
detachable nibs at the other. The four nibs are also made of rigid plastic and can be moved 
to come together and form one sampling tip. The sample collector device was opened from 
the handle end of the package to prevent contamination of the nibs. The tip was checked to 
ensure that the four blue ‘O’ rings were present and accurately positioned at the base of 
each nib. Pointing the collector away from the body, the collar was pushed towards the 
sampling end until an audible click was heard, thereby bringing the four nibs together to 
form a single tip. Sampling was done by directly rubbing the closed nibs of the collector 
device on the swatch (placed flat on a surface) or swab (held in hand) with moderate 
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pressure for thirty seconds while rotating continuously to ensure that all four nibs came 
into contact with the sample. The collector nibs were then separated, inserted into the 
reaction plate and snapped to seal (Figure 6). The handle was rotated clockwise 90° until 
it was severed from the nibs and discarded. The seal on the reaction plate was checked by 
ensuring the proper position of the ‘O’ rings in the wells. The ParaDNAÒ instrument was 
switched on and the instrument head opened by clicking the padlock icon on the screen. 
The reaction plate was then inserted into the instrument head to fit the key configuration 
and the lid closed. The 90-minute analysis was started by pressing the ‘Start’ icon on the 
screen. Positive results for menstrual blood mRNA marker MMP 10were indicated by a 
green check mark on the screen and negative results were indicated by a red cross. Samples 
from all donors were run in triplicate; a total of 18 samples were analyzed. 
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Figure 6: Direct sampling method for ParaDNAÒ Body Fluid ID Test. Top: Separated nibs of 
collector with blue ‘O’ rings, and reaction plate; Below Left: Direct Sampling; Below Right: 
Insertion into reaction plate. 
 
 
 
 
2.3 Method II - SERATECÒ PMB Test 
In all experiments, approximately one-third of the cotton swab or a 5 x 5 mm cutting 
of the cotton swatch was extracted in a microcentrifuge tube in the provided PMB Diluent 
buffer for thirty minutes. The quantity of buffer used was determined by the amount of 
sample present. If only trace amounts of sample were seen visually, 120 µL of buffer was 
used. For all other samples, 300 µL of buffer was utilized.40 After extraction, 120 µL of 
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the extract was added to the sample well of the test cassette and results were read after ten 
minutes. The presence of a pink line at the control region (C) indicated the validity of the 
test. A pink line at both test regions, P and M, and a line at C was recorded as a positive 
reaction, strongly indicating the presence of menstrual blood or a mixture of peripheral and 
menstrual blood. Only a single pink line present at C was recorded as a negative for both 
peripheral and menstrual blood. A pink line at C and P was recorded as negative, indicating 
the absence of menstrual blood, but showing the presence of peripheral blood. The test 
cassette and possible results are shown in Figure 7. Samples from all donors were run in 
triplicate, and a total of 18 samples were analyzed. 
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A.  
B.  
C.  
Figure 7: Results for the SERATECÒ PMB Test. A. Positive for menstrual blood. B. Positive 
for peripheral blood. C. Negative result  
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2.4 Method III- DIMERTESTÒ Latex Assay 
All components were allowed to acclimate to room temperature before starting the 
test. Approximately one-third of the cotton swab or a 5 x 5 mm cutting from the cotton 
swatch was extracted in a microcentrifuge tube in 60 µL of distilled water for thirty 
minutes. Following extraction, the swab/cutting was removed using clean forceps, placed 
in a CostarÒ Spin-XÒ spin basket (Corning Inc., Corning, NY) and centrifuged for ten 
seconds at 14000 rpm. The latex reagent was mixed by inversion and the dropper bottle tip 
was wiped dry prior to each use. Holding the reagent bottle vertically, a drop of the latex 
reagent was placed within a well on the test card. Twenty microliters of the sample extract 
or one drop of the positive/negative control provided was placed next to the latex reagent 
drop. The sample and latex reagent were then mixed with the stirrer provided until 
uniformly distributed. The test card was rocked by hand for three minutes and the results 
were read at the three-minute mark. A strong source of oblique light was used to accurately 
visualize the results. Positive and negative controls were included in each batch of tests. 
The presence of agglutination was recorded as a positive result, whereas the absence of 
agglutination was recorded as a negative (Figure 8). Samples from all donors were run in 
triplicate. 
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Figure 8: Result for the DIMERTESTÒ Latex Assay. Left: No agglutination. Right: Presence of 
agglutination 
 
 
2.5 Method IV- Microscopic Methods 
 Vaginal, buccal and skin cells were collected and fixed to microscope slides in the 
following manner. A sterile cotton swab was rubbed across the interior of the cheek several 
times to collect buccal cells. The swab was then immediately rolled across a clean slide 
and allowed to dry. For the collection of skin cells, a sterile cotton swab was rubbed 
vigorously behind the ear before rolling it across a clean slide.  For vaginal cells, half of a 
dried vaginal swab was extracted in a microcentrifuge tube in distilled water for thirty 
minutes. The swab was then transferred to a spin basket, placed back in the tube and spun 
down at 14000 rpm for 2 minutes. The supernatant was removed without disturbing the 
pellet, leaving approximately 20 µL in the tube. The pellet was resuspended, and 3 µL was 
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placed on a clean slide and allowed to air dry. Two slides were made for each cell type. 
One was stained using Lugol’s Iodine and the other using the Dane’s staining method. 
 
2.5.1 Lugol’s Iodine Staining Method 
 A working solution of Lugol’s iodine was prepared by combining 50 µL of Lugol’s 
stock solution with 950 µL of distilled water. One drop of this working solution was placed 
on the slides and covered with a cover slip. The slides were observed under 400X 
magnification.  The presence of chocolate brown cells indicated the presence of 
glycogenated epithelial cells. More than 10% of glycogenated cells indicated the presence 
of vaginal epithelial cells, while fewer amounts of brown, glycogenated nucleated 
epithelial cells indicated the presence of buccal epithelium. If there was an absence of 
brown cells, the cells appeared fragmented, and showed lack of nuclei, it indicated the 
presence of skin cells. 
 
2.5.2 Dane’s Staining Method 
 Slides containing dried sample were fixed in 100% methanol for ten seconds. 
Following fixation, slides were allowed to air dry and were stained according to Dane’s 
protocol35 as shown below. 
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1. Stained with Mayer’s Haematoxylin 0.1% w/v (Electron Microscopy Sciences, PA) 
for 10 minutes. 
2. Blued in tap water with 10 dips. 
3. Placed in running water for 10 minutes. 
4. Rinsed with distilled water. 
5. Stained with Phloxine B 1% w/v (Electron Microscopy Sciences, PA) for three 
minutes. 
6. Placed in running water for two minutes. 
7. Rinsed with distilled water. 
8. Stained with Alcian Blue 0.5% w/v (Electron Microscopy Sciences, PA) for 10 
minutes. 
9. Placed in running water for two minutes. 
10. Rinsed with distilled water. 
11. Stained with Orange G 0.5% w/v (Electron Microscopy Sciences, PA) for 13 
minutes.  
12. Allowed to dry. 
 
 
CytosealÔ 280 (Richard-Allen Scientific, Kalamazoo, MI, USA) was used to affix the 
coverslips. The slides were examined under 400X magnification. Cells stained red and 
orange with no nuclei indicated skin cells. Cells stained predominantly orange-pink with 
red nuclei indicated buccal cells. Cells stained bright orange with orange nuclei, and with 
a distinct blue hue surrounding the cell indicated vaginal epithelial cells. 
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2.5.3 Menstrual Blood Smears 
 Menstrual blood smears were prepared to assess the applicability of the staining 
methods in cases of sexual assault samples with the presence of blood. One slide was 
prepared for each donor in the following manner, for a total of six slides. A cutting 
measuring approximately 5 x 5 mm or 1/3 of the swab was taken from the sample and 
extracted in a microcentrifuge tube in distilled water for 30 minutes. After this, it was 
transferred to a spin basket, placed back in the tube and centrifuged at 14000 rpm for 2 
minutes. The supernatant was pipetted out without disturbing the pellet, leaving only about 
20 µL. The pellet was resuspended and about 3 µL of this was pipetted on to a clean glass 
slide and allowed to air dry. This was then observed under 100X and 400X magnification 
for the presence of epithelial cells. Following observation of the unstained samples, the 
slides were then stained with Lugol’s iodine as specified above, and again observed at 
400X magnification.  
 
2.6 Simulated Mixture Samples 
2.6.1 Menstrual Blood-Semen Mixture 
 Three 1.5 x 1.5 cm cuttings were taken from a menstrual blood sample deposited 
on a cotton swatch. Fifteen microliters of neat semen were deposited on each cutting and 
allowed to air dry. The cuttings were then each tested using methods I, II and III 
(ParaDNAÒ, PMB and DIMERTESTÒ, respectively). Each method was run in duplicate. 
For ParaDNAÒ, sampling time was extended to 45 seconds, as it has been demonstrated 
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that sensitivity of detecting semen increases when sampling time is increased (personal 
communication). 
 
2.6.2 Peripheral Blood-Semen Mixture 
 Peripheral blood samples collected via finger prick on a filter paper from two 
donors were used. The bloodstains each measured approximately 1.5 cm in diameter on the 
filter paper. Fifteen microliters of neat semen were pipetted on to each stain and allowed 
to air dry. One stain was tested using method I (ParaDNAÒ) and the other was tested using 
methods II and III (PMB and DIMERTESTÒ). Each method was run in duplicate. For 
ParaDNAÒ, once again sampling was performed for 45 seconds. 
 
2.6.3 Peripheral Blood-Vaginal Fluid Mixture 
 Again, peripheral blood samples from two donors were collected via finger prick 
and deposited onto a piece of filter paper. The stains were approximately 1.5 cm in diameter 
on the filter paper. Fifteen microliters of a vaginal swab extract prepared in distilled water 
was pipetted on to each stain and allowed to air dry. One stain was tested with method I 
(ParaDNAÒ) and the other with methods II and III (PMB and DIMERTESTÒ). Each 
method was run in duplicate. 
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3. RESULTS AND DISCUSSION 
3.1 Method I- LGC ParaDNAÒ Body Fluid ID Test 
The ParaDNAÒ Body Fluid ID Test gives a categorical positive or negative result 
in the form of green checkmarks and red crosses, respectively (Figure 9). Five out of the 
six donors gave a 100% positive result for menstrual blood in all replicate samples (Table 
2). One donor consistently showed a negative response for all three replicates. Due to the 
nature of menstrual blood, secretions from the vagina and cervix are often present in 
addition to blood. Therefore, menstrual blood samples can sometimes yield a positive 
response for three markers: blood, menstrual blood and vaginal fluid. However, out of the 
samples positive for menstrual blood, only two donors showed a 100% positive response 
for vaginal fluid, two other donors showed a 33.33% positive response, and the remaining 
one showed a completely negative response for vaginal fluid for all replicates.  
 
 
 
Figure 9: Depiction of example result from ParaDNAÒ Body Fluid ID Test 
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Table 2: ParaDNAÒ Body Fluid ID Test Results. (+) indicates a positive result. (–) indicates a 
negative result. 
 
ParaDNAÒ Body Fluid ID Test 
Donor Collection Type Replicate 
Results 
Menstrual 
Blood 
Percentage 
of positive 
responses 
(%) 
Vaginal 
Fluid 
Percentage 
of positive 
responses 
(%) 
Peripheral 
Blood 
Percentage 
of positive 
responses 
(%) 
A Cotton Swab 
1 + 
100 
+ 
100 
- 
33.33 2 + + + 
3 + + - 
B Cotton Swab 
1 + 
100 
+ 
100 
- 
0 2 + + - 
3 + + - 
C Cotton Swatch 
1 + 
100 
- 
33.33 
- 
0 2 + + - 
3 + - - 
D Cotton Swatch 
1 + 
100 
- 
0 
+ 
66.67 2 + - + 
3 + - - 
E Cotton Swatch 
1 + 
100 
- 
33.33 
- 
0 2 + + - 
3 + - - 
F Cotton Swatch 
1 - 
0 
- 
0 
- 
0 2 - - - 
3 - - - 
 
 
The samples from the two donors with a 100% positive response for vaginal 
secretions were collected on a cotton swab via insertion into the vagina. The other four 
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samples were collected on to a cotton swatch via passive drainage of menstrual blood. This 
difference in collection technique may be the reason for the results mentioned above as the 
direct contact of the swab with the vaginal epithelium likely resulted in a greater 
concentration of cells. Only two donors out of the six showed a positive for peripheral 
blood - Donor A (one out of three replicates) and Donor D (two out of three replicates). It 
is not known why peripheral blood dropped out in some of those samples. The sample 
obtained from Donor F, which was negative throughout, exhibited staining that was visibly 
fainter compared to the others. This may have led to insufficient amounts of the mRNA 
marker MMP-10 and inadequate amplification such that the detection threshold set by the 
instrument was not reached. The default threshold is designed to minimize the occurrence 
of false positives, however, ParaDNAÒ Analysis software is available, which can be used 
to analyze the raw data such as the melt curves. Samples that are negative can be further 
analyzed using this software to assess if peaks are present that fall below the threshold level 
set by the manufacturer. 
A major advantage of the ParaDNAÒ Body Fluid ID Test is that sample preparation 
is very rapid and simple. No extraction is needed and the stain can be sampled dry directly 
or indirectly within 30 seconds to a minute. The single use collection device can then be 
directly inserted into the instrument. The original stain is not consumed and can be utilized 
for further testing, such as DNA profiling. Although the run time of the instrument is 
approximately 90 minutes, an analyst is not needed for any hands-on work during this time. 
The instrument performs the multi-step process of RT-PCR using a single tube with all the 
necessary reagents and primers in an automated fashion. This multiplex method of 
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detection of body fluids is more efficient and less laborious for complicated body fluid 
mixtures, which are common in cases of sexual assault. In instances of single fluid samples, 
such as a suspected bloodstain, a traditional confirmatory method, for example an 
immunoassay card, would be more appropriate. 
 
3.2 Method II- SERATECÒ PMB Test 
 The SERATECÒ PMB test showed the overall best performance. Samples from all 
six donors showed a positive response for menstrual blood in all three replicates, with no 
apparent effect observed due to differences in collection method (Table 3). Using all of the 
provided PMB Diluent buffer for sample extraction decreases the sensitivity of the test, but 
using too concentrated a sample can lead to a high dose hook effect for the detection of 
human hemoglobin or overload the test strips and render it difficult for interpretation. A 
validation study performed with this test40 shows that buffer volume should be chosen 
according to the quantity of the sample as well as the freshness of the sample. For this 
experiment, 300 µl was used for all samples except those that visually presented as having 
only trace amounts of sample; for these, 120 µl of buffer was utilized. The extraction time 
for this test varies from five minutes for extremely fresh samples to about 90 minutes for 
aged samples. In this study, an extraction time of 30 minutes was used for all samples as 
they were similarly aged. The interpretation of the D-dimer line can be difficult without a 
negative control as the intensity can vary with sample amount. Hence, a negative control 
should always be used. The test is similar to current lateral flow immunoassay cards used 
for confirmation of human blood, so special training is not required and this test can be 
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utilized in routine casework quite easily. In addition to this, it is a duplex test, which means 
there is no need to perform an additional test for the confirmation of blood. 
 
Table 3: SERATECÒ PMB Test Results. (+) indicates a positive result. (–) indicates a negative 
result. 
 
SERATECÒ PMB Test 
Donor 
Collection 
Type Replicate 
Results 
Menstrual 
Blood 
Percentage of 
positive responses 
(%) 
Peripheral 
Blood 
Percentage of 
positive responses 
(%) 
A Cotton Swab 
1 + 
100 
+ 
100 2 + + 
3 + + 
B Cotton Swab 
1 + 
100 
+ 
100 2 + + 
3 + + 
C Cotton Swatch 
1 + 
100 
+ 
100 2 + + 
3 + + 
D Cotton Swatch 
1 + 
100 
+ 
100 2 + + 
3 + + 
E Cotton Swatch 
1 + 
100 
+ 
100 2 + + 
3 + + 
F Cotton Swatch 
1 + 
100 
+ 
100 2 + + 
3 + + 
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 One possible issue is that D-dimers can be present in the peripheral blood of people 
with certain blood disorders, and also in post mortem blood; as a result, caution should be 
used when dealing with such cases. Although the test requires some sample preparation, 
an extraction period and a 10-minute test window, it is similar to most tests currently in 
use by forensic laboratories.  
 
3.3 Method III - DIMERTESTÒ Latex Assay 
 The DIMERTESTÒ performed relatively well, giving a positive response in five 
out of six donors. However, Donor A showed a positive in only two of the three replicates 
(Table 4). The level of D-dimer can vary between donors as well as within donors on 
different days of menstruation, which may explain the different results within replicates. 
This test requires the least amount of time to yield a result; however, it must be read at 
exactly three minutes. If this is delayed, the latex suspension may dry out giving a false 
agglutination pattern. A positive and negative control should also be run with every batch 
of tests to ensure accurate interpretation of agglutination. The agglutination is observed 
under a strong light with the naked eye, but can be subjective, especially in cases with trace 
amounts of D-dimer or “borderline” cases.  
 Although the test run time is only 3 minutes, this test required the most time for 
sample preparation. As it is usually used to test human plasma, the instructions call for the 
samples to be centrifuged to minimize cellular matter after an extraction period of 30 
minutes. It also has the same drawback as other D-dimer tests in that it can test positive 
with post mortem blood or blood from individuals with blood disorders such as deep vein 
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thrombosis. In fact, it is a clinical test designed to diagnose those very conditions. It can, 
however, be easily incorporated into the forensic workflow if the above issues are not a 
concern in the given case.  
 
Table 4: DIMERTESTÒ Latex Assay Results. (+) indicates a positive result. (–) indicates a 
negative result. 
 
DIMERTESTÒ Latex 
Donor 
Collection 
Type Replicate 
Results 
Agglutination Observed Percentage of positive responses (%) 
A Cotton Swab 
1 - 
66.67 2 + 
3 + 
B Cotton Swab 
1 + 
100 2 + 
3 + 
C Cotton Swatch 
1 + 
100 2 + 
3 + 
D Cotton Swatch 
1 + 
100 2 + 
3 + 
E Cotton Swatch 
1 + 
100 2 + 
3 + 
F Cotton 
Swatch 
1 - 
0 2 - 
3 - 
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3.4 Method IV - Microscopic Methods 
 The two staining methods were first tested with vaginal, buccal and skin cell smears 
to determine if the stains could differentiate between these three types of cells. Then, 
menstrual blood smears were prepared and examined unstained under the microscope at 
100X and 400X magnification, showing the presence of debris and some epithelial cells in 
all samples (Figure 10). It was not possible to accurately distinguish between the debris 
and cells, and the cells appeared yellow-brown in color, possibly due the presence of 
hemoglobin.  
 
         
Figure 10: Unstained Menstrual Blood Smears. A. Debris observed with reddish-brown 
discoloration of entire slide. B. Yellow-brown cells observed; inset: enlarged view 
 
3.4.1 Lugol’s Staining Method 
With Lugol’s stain it was possible to differentiate the three cell types. The skin cells 
showed the obvious lack of nuclei and were fragmented in appearance. They also stained 
golden yellow due to lack of glycogen. The vaginal cells containing glycogen stained 
A B 
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chocolate brown with a clear round nucleus which was different from the buccal cells, 
which stained golden yellow (Figure 11).  
      
 
Figure 11: Cells stained with Lugol’s Iodine Staining Method. A. Skin Epithelial Cells. B. 
Buccal Epithelial Cells. C. Vaginal Epithelial Cells 
 
This method was then applied to the menstrual blood smears. Most samples showed the 
presence of brownish material (Figure 12), but it was difficult to distinguish between 
cellular debris and epithelial cells. Some samples already showed brownish staining before 
the application of iodine, hence it could not be inferred whether the epithelial cells had 
absorbed the stain or the coloration was due to hemoglobin. In the case of an obvious red-
C 
A B 
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brown stain, it is a possibility that epithelial cells present will already be stained brown 
before the application of iodine, rendering the Lugol’s iodine method ineffective. 
 
 
Figure 12: Menstrual Blood Smear stained with Lugol’s Iodine 
 
3.4.2 Dane’s Staining Method 
 With the application of Dane’s stain, it was possible to distinguish the skin cells 
from the buccal and vaginal cells. The skin cells stained red-orange, with no nuclei and a 
fragmented appearance (Figure 13). According to literature, buccal cells stain orange-pink 
with red nuclei and vaginal cells stain bright orange with orange nuclei and a distinct bluish 
hue39. In this case, however, the buccal and vaginal cells stained similarly with orange-
pink cytoplasm and red nuclei and were indistinguishable from each other. As the staining 
method failed to differentiate between these cell types, further staining was not conducted 
using the menstrual samples. 
39 
 
 
 
 
   
Figure 13: Cells stained with Dane’s Stain. Above: Descriptions of expected images according 
to literature and descriptions of observed.39 Below: Observed images 
 
 
3.5 Comparison Across All Three Methods 
 As the menstrual blood samples were not stained using the Dane’s method and the 
staining with Lugol’s iodine was inconclusive, the staining methods were not further 
considered. The ParaDNAÒ Body Fluid ID Test, SERATECÒ PMB test and the 
DIMERTESTÒ all showed promise for the detection of menstrual blood in forensic samples 
(Figure 14). The SERATECÒ PMB test, however, outperformed the other two tests 
showing a positive response for all replicates of all six donors. 
 
 
Expected: Orange-
pink with red nuclei 
 
Observed: Orange-
pink with red nuclei 
 
 
Expected: Red-orange 
with no nuclei 
 
Observed: Red-orange 
with no nuclei 
 
Expected: Bright 
orange with orange 
nuclei 
Observed: Orange-
pink with red nuclei 
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Figure 14: Graph Comparing Positive Responses Across Methods 
 
3.5.1 Accuracy in Detection  
The reported sensitivities of the PMB test for D-dimer and the DIMERTESTÒ are 
400 ng/mL and 200 ng/ml, respectively.17, 34 In spite of this, Donor F tested positive using 
PMB and negative using the DIMERTESTÒ. As the samples were extracted in distilled 
water in the same manner for both tests, the difference may be due to the non-homogenous 
nature of the sample or unequal distribution of D-dimer deposited onto the cotton swatch. 
Donor A also showed a positive in only two of the three replicates with the DIMERTESTÒ. 
This could be due to not all samples having D-dimer levels high enough to detect or the 
subjectivity of the DIMERTESTÒ with respect to agglutination. The ParaDNAÒ showed a 
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negative for Donor F, but as this test detects mRNA markers and not D-dimer, it cannot 
really be compared with the other two by the sensitivity of detection markers. 
 
3.5.2 Sample Preparation Time 
 The ParaDNAÒ Body Fluid ID Test had the lowest sample preparation time. It 
involved sampling for a few seconds and followed by direct insertion into the instrument. 
The PMB test and the DIMERTESTÒ required an extraction time between 5 and 90 
minutes. They also required part of the sample to be consumed for the test. In contrast to 
this, the ParaDNAÒ did not result in any sample loss. 
 
3.5.3 Analysis Time 
 With a 90-minute run time, the ParaDNAÒ Body Fluid ID Test is the most time 
consuming even though it requires the least amount of time for sample preparation. While 
the instrument is running, however, the analyst is free and does not have to do any hands-
on work. The SERATECÒ PMB test takes 10 minutes to run which is comparable with 
most immunoassay card tests. The DIMERTESTÒ takes only three minutes but has to be 
read at the exact time, as any delays can lead to false positives. 
 
3.5.4 Training Requirements and Cost  
 The SERATECÒ PMB Test and the DIMERTESTÒ Latex Assay require minimal 
training. The PMB test is similar to most immunoassay card tests already in use in forensic 
laboratories, so it would require no additional training for the analyst. The DIMERTESTÒ 
42 
requires a simple extraction step and costs slightly less than the PMB test. In contrast, the 
ParaDNAÒ Body Fluid ID Test has relatively costly associated equipment and reagents. 
Moreover, the analyst is required to go through a training procedure to operate the 
instrument and the software, as well as for the special sampling procedure. 
 
3.6 Simulated Mixture Samples 
 Very often at a crime scene, mixtures of body fluids are found. This is usually the 
case in sexual assault cases. To assess whether the presence of other body fluids influenced 
any of the methods, and also to see if other body fluids mimicked the behavior of menstrual 
blood, mock mixtures were created and analyzed (Figure 15). 
 
 
Figure 15: Graph showing the responses for simulated mixture samples across methods. A 
positive response for semen represents a positive for both seminal fluid and sperm markers. 
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3.6.1 Menstrual Blood-Semen Mixture 
 Expected results were obtained with all three methods of detection. The ParaDNAÒ 
Body Fluid ID Test detected menstrual blood, seminal fluid and sperm in both samples 
(Table 5). The SERATECÒ PMB test showed a positive response for menstrual and 
peripheral blood and the DIMERTESTÒ showed the presence of agglutination in both 
samples (Tables 6 and 7). Hence, the presence of semen did not affect the results, indicating 
that both the RNA marker MMP10 and D-dimer are unaffected by semen and suitable for 
sexual assault evidence. 
 
Table 5: Simulated Mixture Sample Result with the ParaDNAÒ Body Fluid ID Test. (+) 
indicates a positive result. (-) indicates a negative result. 
 
Mixture Results- ParaDNAÒ Body Fluid ID Test 
Sample 
Type Replicate 
Results 
Menstrual 
Blood 
(+) 
(%) 
Vaginal 
Fluid 
(+)  
(%) 
Peripheral 
Blood 
(+)  
(%) Semen* 
(+)  
(%) 
Menstrual 
Blood + 
Semen 
1 + 
100 
- 
0 
- 
0 
+ 
100 
2 + - - + 
Peripheral 
Blood + 
Semen 
1 - 
0 
- 
0 
- 
50 
+ 
100 
2 - - + + 
Peripheral 
Blood + 
Vaginal 
Secretion 
1 - 
0 
+ 
100 
- 
50 
- 
0 
2 - + + - 
*Semen= Sperm + Seminal fluid 
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Table 6: Simulated Mixture Sample Result with the SERATECÒ PMB Test. (+) indicates a 
positive result. (-) indicates a negative result. 
 
Mixture Results- SERATECÒ PMB Test 
Sample Type Replicate 
Results 
Menstrual 
Blood 
Percentage of positive 
responses (%) 
Peripheral 
Blood 
Percentage of positive 
responses (%) 
Menstrual Blood 
+ Semen 
1 + 
100 
+ 
100 
2 + + 
Peripheral Blood 
+ Semen 
1 - 
0 
+ 
100 
2 - + 
Peripheral Blood 
+ Vaginal 
Secretion 
1 - 
0 
+ 
100 
2 - + 
 
 
Table 7: Simulated Mixture Sample Result with the DIMERTESTÒ Latex Assay. (+) indicates 
a positive result. (-) indicates a negative result. 
 
DIMERTESTÒ Latex 
Sample Type Replicate 
Results 
Agglutination Observed Percentage of positive responses (%) 
Menstrual Blood 
+ Semen 
1 + 
100 
2 + 
Peripheral Blood 
+ Semen 
1 - 
0 
2 - 
Peripheral Blood 
+ Vaginal 
Secretion 
1 - 
0 
2 - 
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3.6.2 Peripheral Blood-Semen Mixture 
 The peripheral blood and semen mixture resulted in a negative response for 
menstrual blood with all three methods. This indicates that the tests can accurately 
distinguish between peripheral blood and menstrual blood. Though the ParaDNAÒ Body 
Fluid ID Test did not detect menstrual blood in this mixture, it also did not detect peripheral 
blood in one of the two samples, only detecting semen. This indicates that although the 
specificity of the ParaDNAÒ for menstrual blood is good, the sensitivity for some body 
fluids may decrease with mixture samples. 
 
3.6.3 Peripheral Blood-Vaginal Fluid Mixture 
 Similarly, menstrual blood was not detected in this mixture using any of the three 
methods. This shows that in case of a mixture of vaginal secretions and blood where the 
question of peripheral or menstrual origin is of utmost importance, these tests can be used 
to make an accurate conclusion. However, similar to the above mixture sample, the 
peripheral blood dropped out in one sample when using the ParaDNAÒ Body Fluid ID Test, 
indicating problems with sensitivity and mixture samples. 
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4. CONCLUSIONS 
In cases of alleged sexual assault where the accurate distinction between menstrual 
and peripheral blood is of importance, forensic laboratories should have a reliable 
procedure in place for the detection of menstrual blood. The ParaDNAÒ Body Fluid ID 
Test, SERATECÒ PMB test and the DIMERTESTÒ all show promise for the detection of 
menstrual blood in forensic samples. None of the tests showed a cross reactivity to the 
other body fluids tested. Among these three tests, the SERATECÒ PMB test performed best 
overall with a 100% detection rate within the, albeit small, sample pool. It is also a duplex 
immunoassay that eliminates the need for testing human blood separately. Even though the 
DIMERTESTÒ is the quickest assay to perform, it was slightly less accurate and more 
subjective than the PMB test. An automated multiplex body fluid detection technique 
would be ideal, however, the ParaDNAÒ Body Fluid ID Test demonstrated several 
inaccuracies and decreased sensitivity in mixture samples. Though it accurately detected 
menstrual blood in the majority of samples, it failed in the case of one sample and did not 
accurately detect peripheral blood in two mixed samples.  
Microscopic detection of menstrual blood via detection of vaginal epithelial cells 
could not be accurately investigated as Dane’s staining method could not be reproduced 
and the presence of blood obscured the results for the Lugol’s method. 
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